Tuberculous pleurisy is an infection of the lining around your lungs, called the pleura. It's caused by the tuberculosis bacteria. This infection makes the lining inflamed and irritated, which can cause sharp chest pain, especially when you breathe deeply or cough. It's a serious condition that needs medical treatment.
Every report comes from a Lived member, sent anonymously.
Have you tried Rifampin for Tuberculous Pleurisy?
Tuberculous pleurisy is tuberculosis (TB) affecting the pleura, the thin two-layered lining that wraps the lungs and lines the inside of the chest. The infection inflames this lining, and fluid usually collects between its layers, almost always on one side. Doctors often call this a tuberculous pleural effusion. People typically notice cough, chest pain that is often sharp and worse with a deep breath, and fever, sometimes with weight loss and night sweats. A large collection of fluid can press on the lung and cause breathlessness. The illness often comes on over days to weeks, and it is one of the most common forms of TB outside the lungs. It matters because the effusion can seem to settle on its own while the TB infection is still active elsewhere in the body. In some people the fluid instead thickens into pus (a TB empyema) or leaves lasting scarring around the lung.
Tuberculous pleurisy is caused by Mycobacterium tuberculosis, the same bacterium that causes lung TB. TB spreads through the air when someone with active TB in the lungs or throat coughs, speaks or sings. The pleura becomes involved when infection near the surface of the lung reaches the lining, and much of the swelling and fluid comes from the immune system's strong reaction to a small number of bacteria. Risk follows the same pattern as TB in general. It is higher for people who were born in or spend time in countries where TB is common, who live or work in shelters, prisons or long-term care facilities, or who have close contact with someone with active TB. Pleural TB tends to affect adolescents and younger adults more than other forms of TB. HIV (human immunodeficiency virus), diabetes, medicines that weaken the immune system and heavy alcohol or injected drug use make it more likely that an infection will turn into active disease. In the United States, pleural TB makes up only a small share of TB cases, around 4 percent, so it is often not the first explanation considered for fluid around the lung.
A chest X-ray or ultrasound usually shows the fluid first. A CT (computed tomography) scan can show it in more detail and often reveals TB changes in the lung itself that the X-ray missed. The next step is usually thoracentesis, in which a needle is passed between the ribs to draw off fluid for testing. TB fluid is typically an exudate (fluid rich in protein from inflammation) dominated by lymphocytes, a type of white blood cell. A high level of adenosine deaminase (ADA), an enzyme released by active immune cells, makes TB more likely, especially in someone at higher risk. These findings support the diagnosis but do not prove it, because cancer and some other conditions can produce similar fluid. TB bacteria are scarce in pleural fluid, so cultures and molecular tests on the fluid often come back negative even when TB is present. A pleural biopsy, taking small pieces of the lining with a needle or through a thin camera passed into the chest (thoracoscopy), gives the most reliable answer and allows testing for drug resistance. Sputum (mucus coughed up from the lungs) should be tested too, since many people also have TB in the lung. An HIV test is recommended for everyone diagnosed with TB. Skin and blood tests for TB show past exposure but cannot confirm that the fluid is caused by TB. When the evidence strongly points to TB but no bacteria are found, doctors sometimes start treatment and watch closely to confirm it works and that nothing else is being missed.
Even though the effusion can clear without treatment, more than half of untreated people go on to develop active TB elsewhere, so the condition is treated with a full course of TB medicines. For TB that is not drug resistant, the standard course lasts 6 months: four antibiotics (isoniazid, rifampin, pyrazinamide and ethambutol) for the first 2 months, then isoniazid and rifampin for 4 more. This is the same regimen used for lung TB. Health departments often support people through treatment with directly observed therapy, in which a health worker watches doses being taken in person or by video. These medicines can inflame the liver, which is the most common serious side effect, and ethambutol can affect vision, so blood tests and eye checks are part of follow-up. Drug-resistant TB needs different medicines for longer and is best managed by an experienced TB center. Draining the fluid is done when it causes breathlessness, and it usually brings quick relief. Routine drainage of every effusion has not clearly shown lasting benefit. Fluid that has become pus or divided into pockets usually needs a chest drain, and sometimes surgery (decortication) to peel thick scar tissue off the lung so it can expand. These complicated cases are often treated for longer than 6 months. Steroid medicines such as prednisone may help the fluid clear faster, but they have not been shown to improve long-term breathing and cause more side effects, so they are not used routinely.
Most people start to feel better within the first weeks of treatment, as fever eases and breathing improves. The fluid can take several weeks to months to disappear completely, and imaging is usually repeated to check progress. Some people are left with thickening of the lining that shows on X-rays. How much this affects breathing in the long run is not well understood, but extensive scarring can limit how fully the lung expands. Taking every dose for the full course matters even after symptoms go. Stopping early or missing doses can let TB return and can lead to drug resistance, which is much harder to treat. Regular appointments track side effects, blood tests and response to treatment. Because many people with pleural TB also have TB in the lung, the care team may ask for precautions at home or work at the start of treatment until they confirm the person is not infectious. Occasionally fluid increases for a while after treatment starts even though the medicines are working, so new symptoms are assessed rather than assumed to mean failure.
See a clinician if you have chest pain with breathing, a cough or fever that lasts more than a few weeks, night sweats or unexplained weight loss, especially if you have been exposed to TB or are at higher risk. During treatment, call your care team right away for yellow skin or eyes, dark urine, nausea, vomiting, stomach pain or loss of appetite, which can signal liver injury from the medicines, and for blurred vision or trouble telling colors apart, which can come from ethambutol. Also call promptly if shortness of breath gets worse, or if fever returns after improving. Severe difficulty breathing at rest needs emergency care.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Tuberculous Pleurisy is like, what's helped you, or ask the community a question.